Description
Literature-mined gap from: “A microbiota-derived bile acid overcomes antibiotic-induced hyporesponsiveness to immune checkpoint therapy by enhancing CD8 (+) T cell antitumor immunity” (Li W et al., bioRxiv 2026; PMID 42039389). The paper signals unresolved mechanistic uncertainty in a cancer context.